APVO

APVO · Aptevo Therapeutics Inc. Common Stock

View on chart

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 15, 2026

APVO to Present Multispecific Platform at SITC 2026 Meeting. Aptevo Therapeutics announced it will showcase its multispecific antibody platform at the upcoming SITC 2026 Annual Meeting. The presentation offers the company a chance to highlight its pipeline to a specialized oncology audience. The stock is currently near a support level and has a relatively low RSI, which may reflect recent price pressure.

this person other insiders at APVO

Insiders & Stakes

El-Hibri Fuad
Director
7,373
Shares held
Marvin L. White
Director
1,261
Shares held
Grady Grant III
Director
1,150
Shares held
Jeffrey G. Lamothe
SVP and CFO
961
Shares held
Daphne Taylor
SVP, CFO
638
Shares held
SoYoung Kwon
SVP, GC and Corporate Affairs
638
Shares held
Dirk Huebner
SVP, CMO
482
Shares held
Zsolt Harsanyi
Director
400
Shares held
Daniel Abdun-Nabi
Director
400
Shares held
Barbara Lopez Kunz
Director
400
Shares held
John Niederhuber
Director
400
Shares held
Kevin Tang
10% Owner
0
Shares held

Transaction History

Daphne Taylor▲ Buy—
SoYoung Kwon▲ Buy—
Dirk Huebner▲ Buy—
Dirk Huebner▼ Sell$635
Grady Grant III▲ Buy—
Marvin L. White▲ Buy—
Marvin L. White▼ Sell$2K
Daniel Abdun-Nabi▲ Buy—
Barbara Lopez Kunz▲ Buy—
John Niederhuber▲ Buy—
Zsolt Harsanyi▲ Buy—
Jeffrey G. Lamothe▲ Buy—
Marvin L. White▲ Buy—
Grady Grant III▲ Buy$20K
Zsolt Harsanyi▲ Buy—
Barbara Lopez Kunz▲ Buy—
Daniel Abdun-Nabi▲ Buy—
Grady Grant III▲ Buy—
John Niederhuber▲ Buy—
Daphne Taylor▲ Buy—
SoYoung Kwon▲ Buy—
Marvin L. White▲ Buy—
Jeffrey G. Lamothe▲ Buy—
Daphne Taylor▲ Buy—
Jeffrey G. Lamothe▲ Buy—
Marvin L. White▲ Buy—
SoYoung Kwon▲ Buy—
SoYoung Kwon▲ Buy—
Marvin L. White▲ Buy—
Daphne Taylor▲ Buy—
Jeffrey G. Lamothe▲ Buy—
SoYoung Kwon▲ Buy—
Jeffrey G. Lamothe▲ Buy—
Jeffrey G. Lamothe▲ Buy—
Daphne Taylor▲ Buy—
John Niederhuber▲ Buy—
Zsolt Harsanyi▲ Buy—
Daniel Abdun-Nabi▲ Buy—
Barbara Lopez Kunz▲ Buy—
Grady Grant III▲ Buy—
John Niederhuber▲ Buy—
Zsolt Harsanyi▲ Buy—
Daniel Abdun-Nabi▲ Buy—
Barbara Lopez Kunz▲ Buy—
Grady Grant III▲ Buy—
SoYoung Kwon▲ Buy—
Daphne Taylor▲ Buy—
Jeffrey G. Lamothe▲ Buy—
SoYoung Kwon▲ Buy—
Marvin L. White▲ Buy—
Daphne Taylor▲ Buy—
Jeffrey G. Lamothe▲ Buy—
SoYoung Kwon▲ Buy—
Marvin L. White▲ Buy—
Daphne Taylor▲ Buy—
Jeffrey G. Lamothe▲ Buy—
Marvin L. White▲ Buy—
John Niederhuber▲ Buy—
Barbara Lopez Kunz▲ Buy—
Zsolt Harsanyi▲ Buy—
Grady Grant III▲ Buy—
Daniel Abdun-Nabi▲ Buy—
Daphne Taylor▲ Buy—
SoYoung Kwon▲ Buy—
Jeffrey G. Lamothe▲ Buy—
Jeffrey G. Lamothe▲ Buy—
Grady Grant III▲ Buy—
Barbara Lopez Kunz▲ Buy—
John Niederhuber▲ Buy—
Daniel Abdun-Nabi▲ Buy—
Zsolt Harsanyi▲ Buy—
SoYoung Kwon▲ Buy—
Daphne Taylor▲ Buy—
Jeffrey G. Lamothe▲ Buy—
SoYoung Kwon▲ Buy—
Marvin L. White▲ Buy—
Marvin L. White▲ Buy—
Jeffrey G. Lamothe▲ Buy—
Daniel Abdun-Nabi▲ Buy—
SoYoung Kwon▲ Buy—
Zsolt Harsanyi▲ Buy—
John Niederhuber▲ Buy—
Barbara Lopez Kunz▲ Buy—
Grady Grant III▲ Buy—
Jeffrey G. Lamothe▲ Buy—
Marvin L. White▲ Buy—
El-Hibri Fuad▼ Sell$0
El-Hibri Fuad▼ Sell$0
El-Hibri Fuad▼ Sell$0
Kevin Tang▼ Sell$2.2M
Kevin Tang▼ Sell$1.6M
Kevin Tang▼ Sell$886K
Kevin Tang▼ Sell$1.7M
Kevin Tang▼ Sell$531K
Kevin Tang▼ Sell$2.0M
Kevin Tang▼ Sell$1.5M
Kevin Tang▼ Sell$123K
Kevin Tang▼ Sell$1.4M
Kevin Tang▼ Sell$25K
Kevin Tang▼ Sell$253K
Kevin Tang▼ Sell$1.4M
Kevin Tang▼ Sell$244K
Kevin Tang▼ Sell$1.4M
Kevin Tang▼ Sell$406K
Kevin Tang▼ Sell$1.3M
Kevin Tang▼ Sell$32K
John Niederhuber▲ Buy$650

We use analytics to understand how market-wall is used. No personal data is sold.